Striatal glutamatergic mechanisms and extrapyramidal movement disorders.

Striatal glutamatergic mechanisms and extrapyramidal movement disorders.

Item
http://www.wikidata.org/entity/Q35165439
Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatmentMedication-Induced Tardive Dyskinesia: A Review and Update.Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients.Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations.Supraspinal and spinal alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid and N-methyl-D-aspartate glutamatergic control of the micturition reflex in the urethane-anesthetized rat.Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten diseaseMetabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: ultrastructural localization and electrophysiological effects of activation in the striatopallidal complex.Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient management.Apomorphine and levodopa infusion therapies for advanced Parkinson's disease.Mavoglurant as a treatment for Parkinson's disease.Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and Parkinsonism.Understanding and prevention of "therapy-" induced dyskinesias.Long-Term Effects of Safinamide on Dyskinesia in Mid- to Late-Stage Parkinson's Disease: A Post-Hoc Analysis.Motor Areas Show Altered Dendritic Structure in an Amyotrophic Lateral Sclerosis Mouse Model.Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease.Role of metabotropic glutamate receptors in the mechanisms of experimental parkinsonism development.Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model.
P2860

Striatal glutamatergic mechanisms and extrapyramidal movement disorders.

Item
http://www.wikidata.org/entity/Q35165439
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Striatal glutamatergic mechanisms and extrapyramidal movement disorders.
@ast
Striatal glutamatergic mechanisms and extrapyramidal movement disorders.
@en
type
label
Striatal glutamatergic mechanisms and extrapyramidal movement disorders.
@ast
Striatal glutamatergic mechanisms and extrapyramidal movement disorders.
@en
prefLabel
Striatal glutamatergic mechanisms and extrapyramidal movement disorders.
@ast
Striatal glutamatergic mechanisms and extrapyramidal movement disorders.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Striatal glutamatergic mechanisms and extrapyramidal movement disorders.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P921